Bharat Biotech commences Phase III trials for COVAXIN
Phase III trials will involve 26,000 volunteers across India who will receive two intramuscular injections, approximately 28 days…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Catalent completes acquisition of Bone Therapeutics’ cell therapy manufacturing subsidiary SCTS
The gross proceeds of the deal are €12 million
Study recommends steroid treatment should be given only to sickest COVID-19 patients
While dexamethasone and other steroids are prescribed to treat cytokine storms, these drugs can backfire in patients whose immune…
Case Study: Sustainable, decentralised, waste management system
Dr Aparna Pandey, Head - Research wing, Monisha Narke , Founder and CEO and Pradnya Bandvdekar, Project Operations Executive, RUR…
Government asks PCI to respond to KSRPO’s letter
The association has asked the PCI to pass a resolution that medical shop licenses should be granted to only registered pharmacists
Sanofi invests 50 million euros in Jeito Capital
The investment will be deployed by Jeito’s team, in line with its investment criteria, to support French and European healthcare…
Israel to enter into a deal with Pfizer for COVID-19 vaccine
The supply would begin in January 2021, with the remainder arriving throughout the course of 2021: Israel’s Health Minister
NATCO gets US FDA approval for Pomalidomide capsules
It is indicated for the treatment of multiple myeloma
Dr Reddy’s launches Succinylcholine Chloride Injection in US
It is a sterile, nonpyrogenic solution to be used as an ultra-short acting, depolarizing, skeletal muscle relaxant
Industry associations appoint PwC as advisor to attract investments in pharma
The agency will help achieve the vision of becoming a $120 billion industry by 2030
Gates Foundation offers $70 mn additional funding for COVID-19 vaccines
$50 million will go to the COVAX Advance Market Commitment (AMC) and $20 million to the Coalition for Epidemic Preparedness…
Lupin’s alliance partner Concord gets USFDA nod for Tacrolimus Capsules
They are indicated for prophylaxis of organ rejection in adult and paediatric patients receiving allogeneic liver, kidney or heart…
Govt allots R&D grant of Rs 900 crores for COVID-19 vaccine development
The grant does not cover the cost of vaccine and distribution expenses
Amneal gets US FDA approval for Acyclovir Cream
It is indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of…
Zydus concludes Phase II trials of Pegylated Interferon alpha-2b for COVID-19, to begin Phase III…
In 19 out of 20 patients, a single 1 mcg/kg dose of the drug demonstrated viral clearance as assessed by RT-PCR and a significant…
1600 participants enrolled for Phase III clinical trials of Covishield
SII and ICMR are conducting Phase 2/3 clinical trial of COVISHIELD at 15 different centres, across the country
COVID-19 forced pharma to shuffle technology investment priorities: GlobalData
Social media and cloud computing became the most dominant technologies for current investments for pharma in 2020
Inadequate cold chain infra may limit India’s access to Pfizer’s COVID-19 vaccine
Pfizer’s vaccine needs to stored and transported at -70 degree Celsius to maintain its efficacy
Vor Biopharma signs exclusive license pact with NCI for clinical-stage CD33 CAR-T
It is currently being evaluated in a multi-site Phase 1/2 clinical trial in children and young adults with relapsed or refractory…
Industry appreciate Cabinet sanction of Rs 15000 crores for pharma PLI scheme
Stakeholders feel that it is a timely action towards making the industry self-reliant